> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Conference on Evaluating Drug Liver Injuries
- URL: https://www.fdaweb.com/conference-on-evaluating-drug-liver-injuries/
- Published: 2016-01-15T12:00:00.000Z
- Updated: 2026-09-15T02:28:09.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5134457

*Federal Register* Notice: FDA will hold a public conference 3/23-24 entitled “How Should Liver Injury and Dysfunction Caused by Drugs Be Measured, Evaluated, and Acted Upon in Clinical Trials?” This conference will be co-sponsored with the Critical Path Institute and will discuss, debate, and share views among stakeholders. It will be held 3/23, from 8 a.m. to 6 p.m., and 3/24, from 8 a.m. to 4 p.m. at the College Park Marriott Hotel & Conference Center, 3501 University Blvd., East Hyattsville, MD. Contact **Lana L. Pauls**, (301) 796-0518, lana.pauls@fda.hhs.gov. To view this notice, click [here.](https://www.gpo.gov/fdsys/pkg/FR-2016-01-15/pdf/2016-00690.pdf?ref=fdaweb.com)